A retrospective, real world study of comparing four direct oral anticoagulants (DOACs) to warfarin in Asians patients with non-valvular atrial fibrillation
Latest Information Update: 19 Jul 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Haemorrhage; Ischaemic stroke; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 08 Jul 2021 Results investigating the effectiveness and safety of NOACs versus warfarin among patients with atrial fibrillation with cancer published in the Stroke
- 22 May 2019 New trial record
- 16 May 2019 Results evaluating the superiority of DOACs to warfarin are published in the Chest.